Clinical Study of Perforated Duodenal Ulcer.
- Author:
Kyung Hwa PARK
1
;
Ho Sung KIM
;
Chin Seung KIM
;
Kwang Chan LEE
;
Sin Hee PARK
;
Sang Yong CHOI
;
Gook Hyun BAE
Author Information
1. Department of Surgery, Sung-Ae Hospital, Korea. DP9228A@lycos.co.kr
- Publication Type:Original Article
- Keywords:
Perforated duodenal ulcer;
H2 blocker;
Proton pump inhibitor;
Recurrence;
Mortality
- MeSH:
Duodenal Ulcer*;
Follow-Up Studies;
Helicobacter pylori;
Humans;
Mortality;
Operative Time;
Peptic Ulcer;
Proton Pumps;
Recurrence;
Retrospective Studies;
Ulcer
- From:Journal of the Korean Surgical Society
2003;65(5):402-407
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: There has been considerable controversy about whether acid reduction surgery is a definitive surgical treatment for perforated duodenal ulcer with numerous methods having been described. The controversy has increased with the development of the Proton Pump inhibitor and the discovery of Helicobacter Pylori (HP), because the recurrence and morbidity have been shown to decrease with simple closure followed by a good medical therapy against HP and the ulcer. This study is an evaluation of simple closure as an alternative treatment of perforated duodenal ulcer. METHODS: This retrospective study reviewed the records of 288 patients with surgically-treated ulcer perforation. After 62 patients were excluded, 128 patients treated with simple closure were compared with 98 patients treated with definitive surgery. In the simple closure group, we compared 50 patients treated with Proton Pump inhibitor and 78 patients treated with H2 blocker. Also, the influence of various factors such as age, delayed operation, size of ulcer perforation, operative methods, associated diseases, and complications were analyzed to evaluate recurrence, morbidity and mortality. RESULTS: After mean follow up for 53.7 months, 56.6% of patients treated with simple closure had fewer post operative complications and a lower recurrence rate compared with definitive surgery. The infection rate by HP of 81.6% in our study was similar to that of other studies. Some factors as age (>60), duration of symptoms (>24 hours), size of ulcer perforation (>10 mm), associated disease and operative time showed an influence on the mortality. CONCLUSION: Recent advances in the treatment of perforated peptic ulcer such as the development of the Proton Pump inhibitor and the discovery of HP have shown that after simple closure, an adequate medical treatment of ulcer can effectively decrease the recurrence rate, morbidity and mortality.
